About Us
Who We Are
The Association for Ocular Pharmacology and Therapeutics (AOPT) serves as a global, interdisciplinary platform dedicated to advancing the science and application of therapies for ocular diseases. It fosters the dissemination, exchange, and critical evaluation of knowledge spanning basic and clinical ocular pharmacology, therapeutics, biologics, pharmacokinetics and pharmacodynamics, drug metabolism, translational science, safety, and innovative drug delivery systems.
AOPT is committed to catalyzing scientific progress by promoting rigorous research, facilitating collaboration between academia, industry, and regulatory stakeholders, and enabling the development of next-generation therapeutics, including small molecules, biologics, and advanced modalities. The organization prioritizes forward-looking dialogue to identify unmet clinical needs and define future intervention strategies in ophthalmology and vision science.
As a convening body, AOPT cultivates an environment of transparent and constructive engagement, supporting the integration of scientific discovery with clinical application and commercial translation. It actively contributes to workforce development by fostering high-quality training, mentorship, and professional growth opportunities across career stages, with particular emphasis on equipping trainees and early-career scientists with skills in peer review, critical thinking, and translational research.
AOPT also functions as a global think tank, connecting emerging and mid-sized biopharmaceutical enterprises with investors and collaborators, while supporting decentralized scientific exchange through regional and virtual forums worldwide. By empowering diverse voices—including trainees—to shape the future of the field, AOPT advances a collaborative, inclusive, and innovation-driven ecosystem.
Ultimately, AOPT is dedicated to improving patient outcomes by accelerating the development, evaluation, and implementation of safe and effective ocular therapeutics across the full spectrum of modalities, including biologics.
Become a Member
Become a member and enjoy all the benefits.
Mission
To serve as a global forum and network for the publication, dissemination and exchange of information and knowledge on treatments of eye diseases, from basic and clinical ocular pharmacology and therapeutics to related disciplines such as pharmacokinetics and dynamics, metabolism, translational research, safety, drug delivery, and pharmaceutic
- To promote the advancement of research and scientific progress in these fields
- To assist researchers and eye-care professionals in furthering their understanding of the treatment of ocular disorders
Nomination of Trustees
AOPT requests nominations for Trustee to serve on the AOPT Board.
- Nomination deadline is December 31.
- Ballots will go out in early January.
- Voting deadline is January 31.
- Election Results announced at the Biennial AOPT Business meeting,
Members may nominate themselves or one or more other members. Each nominee must provide a brief biographical sketch, how they have supported AOPT in the past and intend to do so if elected.
Nomination of AOPT Fellows
Eligibility for Fellows of the Association for Ocular Pharmacology and Therapeutics
- Membership (1 point/year)
- Abstract submission to the AOPT Congress (1 point)
- Paper submission to JOPT (2 points)
- Board service (1 point/year)
- JOPT reviews (1 point/review)
- Editorial Board service (1 point/year)
- Scientific program responsible for AOPT Congress (2 points)
Minimum requirement: 20 points
Method for selection of AOPT Fellows:
- Board of Directors appointment
Timing: AOPT fellows should be nominated by the end of each calendar year.
Deadline for Board of Directors nominations: 12/31
Schedule of AOPT Board of Trustees Meetings
The AOPT board of trustees meets monthly during the academic year.
The board of trustees holds an open meeting for all members during each of its biennial meetings. The agenda for the open meeting will be sent to all registered members of the AOPT.